ATP analogues with modified phosphate chains and their selectivity for rat P2X 2 and P2X 2/3 receptors

British Journal of Pharmacology

Volumn 140, Issue 6, 2003, Pages 1027-1034

  Spelta, Valeria ^a,b   Mekhalfia, Abdelaziz ^a   Rejman, Dominik ^a   Thompson, Mark ^a   Blackburn, G Michael ^a   North, R Alan ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Electrophysiology; P2X receptors; Phosphate chain

Indexed keywords

ADENOSINE DIPHOSPHATE DERIVATIVE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ADENYLYLIMIDODIPHOSPHATE; ALPHA,BETA ACETYLENEADENOSINE DIPHOSPHATE; ALPHA,BETA DIFLUOROMETHYLENEADENOSINE TRIPHOSPHATE; ALPHA,BETA ETHYLENEADENOSINE DIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ALPHA,BETA,BETA,GAMMA BISMETHYLENEADENOSINE 5' TETRAPHOSPHATE; BETA,GAMMA ACETYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA BROMOMETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA CARBOXYMETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA CHLOROMETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA CHLOROPHOSPHONOMETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA DIBROMOMETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA ETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA FLUOROPHOSPHONOMETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA PHOSPHONOMETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA SULFONOMETHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA,GAMMA,DELTA BISMETHYLENEADENOSINE 5' TETRAPHOSPHATE; CARBENOID; OXYGEN; PHOSPHORUS DERIVATIVE; PURINE P2X2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROPHYSIOLOGY; EMBRYO; HUMAN; HUMAN CELL; IC 50; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; SENSORY NERVE CELL;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE; CHILD, PRESCHOOL; DIMERIZATION; DIPHOSPHATES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MEMBRANE POTENTIALS; POLYPHOSPHATES; RATS; RECEPTORS, PURINERGIC P2;

EID: 0142093932     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705531     Document Type: Article

References (46)

1. BAUER, C.B., FONSECA, M.V., HOLDEN, H.M., THODEN, J.B., THOMPSON, T.B., ESCALANTE-SEMERENA, J.C. & RAYMENT, I. (2001). Three-dimensional structure of ATP:corrinoid adenosyltransferase from Salmonella typhimurium in its free state, complexed with MgATP, or complexed with hydroxycobalamin and MgATP. Biochemistry, 40, 361-374.
2. BLACKBURN, G.M., ECKSTEIN, F., KENT, D.E. & PERRÉE, T.D. (1985). Isopolar vs isosteric phosphonate analogues of nucleotides. Nucleosides Nucleotides, 4, 165-167.
3. BLACKBURN, G.M. & LANGSTON, S.P. (1991). Novel P1,P2-substituted phosphonate analogues of 2′-deoxyadenosine and thymidine 5′-triphosphates. Tetrahedron Lett., 32, 6425-6428.
4. BLACKBURN, G.M., KENT, D.E. & KOLKMANN, F. (1984). The synthesis and metal binding characteristics of novel, isopolar phosphorate analogues of nucleotides. J. Chem. Soc. Perkin Trans., 15, 1119-1125.
5. BLEEHEN, T. & KEELE, C.A. (1977). Observations on the algogenic actions of adenosine compounds on the human blister base. Pain, 3, 365-371.
6. 3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol. Cell. Neurosci., 12, 256-268.
7. 2/3 receptors by 2′, 3′-O-(2,4,6- trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP). Mol. Pharmacol., 58, 1502-1510.
8. CHEN, C.-C., AKOPIAN, A.N., SIVILOTTI, L., COLQUHOUN, D., BURNSTOCK, G. & WOOD, J.N. (1995). A P2X purinoceptor expressed by a subset of sensory neurons. Nature, 377, 428-431.
9. 3-deficient mice. Nature, 407, 1011-1015.
10. COOK, S.P., VULCHANOVA, L., HARGREAVES, K.M., ELDE, R. & MCCLESKEY, E.W. (1997). Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature, 387, 505-508.
11. DAVISSON, V.J., DAVIS, D.R., DIXIT, V.M. & POULTER, C.D. (1987). Synthesis of nucleotide 5′-diphosphates from 5′-O-tosyl nucleosides. J. Org. Chem., 52, 1794-1801.
12. DUNN, P.M., ZHONG, Y. & BURNSTOCK, G. (2001). P2X receptors in peripheral neurons. Prog. Neurobiol., 65, 107-134.
13. EVANS, R.J., LEWIS, C., BUELL, G., VALERA, S., NORTH, R.A. & SURPRENANT, A. (1995). Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X-purinoceptors). Mol. Pharmacol., 48, 78-183.
14. FERGUSON, D.R., KENNEDY, I. & BURTON, T.J. (1997). ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - a possible sensory mechanism? J. Physiol., 505, 503-511.
15. GRUBB, B.D. & EVANS, R.J. (1999). Characterization of dorsal root ganglion neuron P2X receptors. Eur. J. Neurosci., 11, 49-54.
16. HAZES, B., BOODHOO, A., COCKLE, S.A. & READ, R.J. (1996). Crystal structure of the pertussis toxin-ATP complex: a molecular sensor. J. Mol. Biol., 258, 661-671.
17. 3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics. Pain, 96, 99-105.
18. INGALL, A.M., DIXON, J., BAILEY, A., COOMBS, M.E., COX, D., MCINALLY, J.I., HUNT, S.F., KINDON, N.D., TEOBALD, B.J., WILLIS, P.A., HUMPHRIES, R.G., LEFF, P., CLEGG, J.A., SMITH, J.A. & TOMLINSON, W. (1999). Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J. Med. Chem., 42, 213-220.
19. JACOBSON, K.A., HOFFMANN, C., KIM, Y.-C., CAMAIONI, E., NANDANAN, E., JANG, S.Y., GUO, D.-P., JI, X.-D., VON, KUGELGEN I., MORO, S., ZIGANSHIN, A.U., RYCHKOV, A., KING, B.F., BROWN, S.G., WILDMAN, S.S., BURNSTOCK, G., BOYER, J.L., MOHANRAM, A. & HARDEN, T.K. (1999). Molecular recognition in P2 receptors: ligand development aided by molecular modelling and mutagenesis. Prog. Brain Res., 120, 119-134.
20. JACOBSON, K.A. & KNUTSEN, L.J.S. (2001). P1 and P2 purine and pyrimidine receptor ligands. In: Purinergic and Pyrimidinergic signalling I, Handbook of Experimental Pharmacology, ed. Abbracchio, M.P. & Williams, M. pp. 129-175. Berlin: Springer.
21. 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. U.S.A., 99, 17179-17184.
22. JIANG, L.H., RASSENDREN, F., SURPRENANT, A. & NORTH, R.A. (2000). Identification of amino acid residues contributing to the ATP-binding site of a purinergic P2X receptor. J. Biol. Chem., 275, 34190-34196.
23. KAWASHIMA, E., ESTOPPEY, D., FAHMI, D., VIRGINIO, C., REES, S., SURPRENANT, A. & NORTH, R.A. (1998). A novel and efficient method for the stable expression of heteromeric ion channels in mammalian cells. Recept. Channels, 5, 53-60.
24. LABRAKAKIS, C., GERSTNER, E. & MACDERMOTT, A.B. (2000). Adenosine triphosphate-evoked currents in cultured dorsal root ganglion neurons obtained from rat embryos: desensitization kinetics and modulation of glutamate release. Neuroscience, 101, 1117-1126.
25. LEFF, P., WOOD, B.E., O'CONNOR, S.E. & MCKECHNIE, K. (1993). Quantitative analysis of the agonist and antagonist actions of some ATP analogues at P2X-purinoceptors in the rabbit ear artery. Br. J. Pharmacol., 108, 490-496.
26. 2X3 receptor subunits can account for ATP-gated currents in sensory neurones. Nature, 377, 432-434.
27. LEWIS, C.J., SURPRENANT, A. & EVANS, R.J. (1998). 2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP) - a nano-molar antagonist at rat mesenteric artery P2X ion channels. Br. J. Pharmacol., 124, 1463-1466.
28. LI, C., PEOPLES, R.W., LANTHORN, T.H., LI, Z.-W. & WEIGHT, F.F. (1999). Distinct ATP-activated currents in different types of neurons dissociated from rat dorsal root ganglion. Neurosci. Lett., 263, 57-60.
29. 2 receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons. J. Pharmacol. Exp. Ther., 296, 1043-1050.
30. LIU, X., BRENNER, C., GURANOWSKI, A., STARZYNSKA, E. & BLACKBURN, G.M. (1999). New tripodal 'supercharged' analogues of adenosine nucleotides: inhibitors for the Fhit Ap3A hydrolase. Angew. Chem., 38, 1244-1247.
31. NORTH, R.A. (2002). The molecular physiology of P2X receptors. Physiol. Rev., 82, 1013-1067.
32. NORTH, R.A. & SURPRENANT, A. (2000). Pharmacology of P2X receptors. Annu. Rev. Pharmacol. Toxicol., 40, 563-580.
33. 3 receptors. J. Neurosci., 17, 6529-6533.
34. 3-receptors present in neurones of the rat dorsal root ganglia. Br. J. Pharmacol., 124, 176-180.
35. RAMAKRISHNAN, C., DANI, V.S. & RAMASARMA, T. (2002). A conformational analysis of Walker motif A [GXXXXGKT(S)] in nucleotide-binding and other proteins. Prot. Eng., 15, 783-798.
36. 2/3 heteromeric receptors. Br. J. Pharmacol., 135, 1524-1530.
37. 3 receptors. Nature, 407, 1015-1017.
38. THOMAS, S., VIRGINIO, C., NORTH, R.A. & SURPRENANT, A. (1998). The antagonist trinitrophenyl-ATP reveals co-existence of distinct P2X receptor channels in rat nodose neurones. J. Physiol., 509, 411-417.
39. TORRES, G.E., EGAN, T.M. & VOIGT, M.M. (1999). Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J. Biol. Chem., 274, 6653-6659.
40. TRAUT, T.W. (1994). The functions and consensus motifs of nine types of peptide segments that form different types of nucleotide-binding sites. Eur. J. Biochem., 222, 9-19.
41. UENO, S., TSUDA, M., IWANAGA, T. & INOUE, K. (1999). Cell type-specific ATP-activated responses in rat dorsal root ganglion neurons. Br. J. Pharmacol., 126, 429-436.
42. 3 receptors, and receptors in rat nodose neurones. J. Physiol., 510, 27-35.
43. 2/3 receptors. Mol. Pharmacol., 53, 969-973.
44. 3 knock-out mice reveal a major sensory role for urothelially released ATP. J. Neurosci., 21, 5670-5677.
45. 3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology, 36, 1229-1242.
46. 3 is expressed by DRG neurons that terminate in inner lamina II. Eur. J. Neurosci., 10, 3470-3478.